Prime Medicine, Inc. - Common Stock, par value $0.00001 per share (PRME)

Historical Holders from Q4 2022 to Q1 2025

Symbol
PRME on Nasdaq
CUSIP
74168J101
Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
130M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
64.3M
Holdings value
$188M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
129
Number of buys
63
Number of sells
-50
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Prime Medicine, Inc. - Common Stock, par value $0.00001 per share (PRME)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Newpath Partners, L.P. 4.7% $12.2M 6.11M Newpath Partners, L.P. Dec 31, 2024

Institutional Holders of Prime Medicine, Inc. - Common Stock, par value $0.00001 per share (PRME)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 280K $550K +$86.5K $1.99 10
2024 Q4 64.3M $188M -$16.4M $2.92 129
2024 Q3 68.7M $266M -$1.69M $3.87 113
2024 Q2 68.9M $354M +$8.57M $5.14 119
2024 Q1 66.7M $467M +$126M $7.00 112
2023 Q4 48.5M $429M -$12M $8.86 101
2023 Q3 49.5M $472M +$28.5M $9.54 82
2023 Q2 46.1M $676M +$67.1M $14.65 77
2023 Q1 41.7M $512M +$3.23M $12.30 73
2022 Q4 41.3M $768M +$767M $18.58 65